Compile Data Set for Download or QSAR
Report error Found 52 Enz. Inhib. hit(s) with all data for entry = 50016022
TargetCytochrome P450 4F2(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50591500(CHEMBL5195099)
Affinity DataIC50: 6.5nMAssay Description:Inhibition of human recombinant CYP4F2 using Luciferin-4F2/3 as substrate incubated for 60 mins in presence of NADPH regenerating system by luminesce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2023
Entry Details
PubMed
TargetCytochrome P450 4F2(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50591501(CHEMBL5183418)
Affinity DataIC50: 15nMAssay Description:Inhibition of human recombinant CYP4F2 using Luciferin-4F2/3 as substrate incubated for 60 mins in presence of NADPH regenerating system by luminesce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2023
Entry Details
PubMed
TargetCytochrome P450 4F2(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50591496(CHEMBL5204432)
Affinity DataIC50: 17nMAssay Description:Inhibition of human recombinant CYP4F2 using Luciferin-4F2/3 as substrate incubated for 60 mins in presence of NADPH regenerating system by luminesce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2023
Entry Details
PubMed
TargetCytochrome P450 4A11(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50591496(CHEMBL5204432)
Affinity DataIC50: 19nMAssay Description:Inhibition of human recombinant CYP4A11 using Luciferin-4A as substrate incubated for 60 mins in presence of NADPH regenerating system by luminescenc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2023
Entry Details
PubMed
TargetCytochrome P450 4F2(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50591519(CHEMBL5174407)
Affinity DataIC50: 19nMAssay Description:Inhibition of human recombinant CYP4F2 using Luciferin-4F2/3 as substrate incubated for 60 mins in presence of NADPH regenerating system by luminesce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2023
Entry Details
PubMed
TargetCytochrome P450 4F2(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50591499(CHEMBL5173608)
Affinity DataIC50: 21nMAssay Description:Inhibition of human recombinant CYP4F2 using Luciferin-4F2/3 as substrate incubated for 60 mins in presence of NADPH regenerating system by luminesce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2023
Entry Details
PubMed
TargetCytochrome P450 4A11(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50591520(CHEMBL5169535)
Affinity DataIC50: 29nMAssay Description:Inhibition of human recombinant CYP4A11 using Luciferin-4A as substrate incubated for 60 mins in presence of NADPH regenerating system by luminescenc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2023
Entry Details
PubMed
TargetCytochrome P450 4F2(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50591520(CHEMBL5169535)
Affinity DataIC50: 36nMAssay Description:Inhibition of human recombinant CYP4F2 using Luciferin-4F2/3 as substrate incubated for 60 mins in presence of NADPH regenerating system by luminesce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2023
Entry Details
PubMed
TargetCytochrome P450 4A11(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50591505(CHEMBL5199278)
Affinity DataIC50: 38nMAssay Description:Inhibition of human recombinant CYP4A11 using Luciferin-4A as substrate incubated for 60 mins in presence of NADPH regenerating system by luminescenc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2023
Entry Details
PubMed
TargetCytochrome P450 4F2(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50591510(CHEMBL5206230)
Affinity DataIC50: 40nMAssay Description:Inhibition of human recombinant CYP4F2 using Luciferin-4F2/3 as substrate incubated for 60 mins in presence of NADPH regenerating system by luminesce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2023
Entry Details
PubMed
TargetCytochrome P450 4A11(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50591506(CHEMBL5189943)
Affinity DataIC50: 41nMAssay Description:Inhibition of human recombinant CYP4A11 using Luciferin-4A as substrate incubated for 60 mins in presence of NADPH regenerating system by luminescenc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2023
Entry Details
PubMed
TargetCytochrome P450 4F2(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50591497(CHEMBL5192170)
Affinity DataIC50: 44nMAssay Description:Inhibition of human recombinant CYP4F2 using Luciferin-4F2/3 as substrate incubated for 60 mins in presence of NADPH regenerating system by luminesce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2023
Entry Details
PubMed
TargetCytochrome P450 4A11(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50591502(CHEMBL5205521)
Affinity DataIC50: 63nMAssay Description:Inhibition of human recombinant CYP4A11 using Luciferin-4A as substrate incubated for 60 mins in presence of NADPH regenerating system by luminescenc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2023
Entry Details
PubMed
TargetCytochrome P450 4F2(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50591518(CHEMBL5172100)
Affinity DataIC50: 63nMAssay Description:Inhibition of human recombinant CYP4F2 using Luciferin-4F2/3 as substrate incubated for 60 mins in presence of NADPH regenerating system by luminesce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2023
Entry Details
PubMed
TargetCytochrome P450 4F2(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50591498(CHEMBL5180285)
Affinity DataIC50: 66nMAssay Description:Inhibition of human recombinant CYP4F2 using Luciferin-4F2/3 as substrate incubated for 60 mins in presence of NADPH regenerating system by luminesce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2023
Entry Details
PubMed
TargetCytochrome P450 4F2(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50591504(CHEMBL5208981)
Affinity DataIC50: 69nMAssay Description:Inhibition of human recombinant CYP4F2 using Luciferin-4F2/3 as substrate incubated for 60 mins in presence of NADPH regenerating system by luminesce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2023
Entry Details
PubMed
TargetCytochrome P450 4A11(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50591508(CHEMBL5192567)
Affinity DataIC50: 70nMAssay Description:Inhibition of human recombinant CYP4A11 using Luciferin-4A as substrate incubated for 60 mins in presence of NADPH regenerating system by luminescenc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2023
Entry Details
PubMed
TargetCytochrome P450 4F2(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50591517(CHEMBL5183091)
Affinity DataIC50: 73nMAssay Description:Inhibition of human recombinant CYP4F2 using Luciferin-4F2/3 as substrate incubated for 60 mins in presence of NADPH regenerating system by luminesce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2023
Entry Details
PubMed
TargetCytochrome P450 4F2(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50591503(CHEMBL5195431)
Affinity DataIC50: 96nMAssay Description:Inhibition of human recombinant CYP4F2 using Luciferin-4F2/3 as substrate incubated for 60 mins in presence of NADPH regenerating system by luminesce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2023
Entry Details
PubMed
TargetCytochrome P450 4F2(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50591516(CHEMBL5199197)
Affinity DataIC50: 110nMAssay Description:Inhibition of human recombinant CYP4F2 using Luciferin-4F2/3 as substrate incubated for 60 mins in presence of NADPH regenerating system by luminesce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2023
Entry Details
PubMed
TargetCytochrome P450 4A11(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50591510(CHEMBL5206230)
Affinity DataIC50: 140nMAssay Description:Inhibition of human recombinant CYP4A11 using Luciferin-4A as substrate incubated for 60 mins in presence of NADPH regenerating system by luminescenc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2023
Entry Details
PubMed
TargetCytochrome P450 4A11(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50591497(CHEMBL5192170)
Affinity DataIC50: 160nMAssay Description:Inhibition of human recombinant CYP4A11 using Luciferin-4A as substrate incubated for 60 mins in presence of NADPH regenerating system by luminescenc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2023
Entry Details
PubMed
TargetCytochrome P450 4F2(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50591514(CHEMBL5184859)
Affinity DataIC50: 170nMAssay Description:Inhibition of human recombinant CYP4F2 using Luciferin-4F2/3 as substrate incubated for 60 mins in presence of NADPH regenerating system by luminesce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2023
Entry Details
PubMed
TargetCytochrome P450 4F2(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50591509(CHEMBL5191778)
Affinity DataIC50: 180nMAssay Description:Inhibition of human recombinant CYP4F2 using Luciferin-4F2/3 as substrate incubated for 60 mins in presence of NADPH regenerating system by luminesce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2023
Entry Details
PubMed
TargetCytochrome P450 4A11(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50591504(CHEMBL5208981)
Affinity DataIC50: 210nMAssay Description:Inhibition of human recombinant CYP4A11 using Luciferin-4A as substrate incubated for 60 mins in presence of NADPH regenerating system by luminescenc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2023
Entry Details
PubMed
TargetCytochrome P450 4F2(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50591515(CHEMBL5203135)
Affinity DataIC50: 220nMAssay Description:Inhibition of human recombinant CYP4F2 using Luciferin-4F2/3 as substrate incubated for 60 mins in presence of NADPH regenerating system by luminesce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2023
Entry Details
PubMed
TargetCytochrome P450 4A11(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50591509(CHEMBL5191778)
Affinity DataIC50: 220nMAssay Description:Inhibition of human recombinant CYP4A11 using Luciferin-4A as substrate incubated for 60 mins in presence of NADPH regenerating system by luminescenc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2023
Entry Details
PubMed
TargetCytochrome P450 4A11(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50591498(CHEMBL5180285)
Affinity DataIC50: 260nMAssay Description:Inhibition of human recombinant CYP4A11 using Luciferin-4A as substrate incubated for 60 mins in presence of NADPH regenerating system by luminescenc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2023
Entry Details
PubMed
TargetCytochrome P450 4F2(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50591502(CHEMBL5205521)
Affinity DataIC50: 260nMAssay Description:Inhibition of human recombinant CYP4F2 using Luciferin-4F2/3 as substrate incubated for 60 mins in presence of NADPH regenerating system by luminesce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2023
Entry Details
PubMed
TargetCytochrome P450 4A11(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50591517(CHEMBL5183091)
Affinity DataIC50: 310nMAssay Description:Inhibition of human recombinant CYP4A11 using Luciferin-4A as substrate incubated for 60 mins in presence of NADPH regenerating system by luminescenc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2023
Entry Details
PubMed
TargetCytochrome P450 4A11(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50591499(CHEMBL5173608)
Affinity DataIC50: 370nMAssay Description:Inhibition of human recombinant CYP4A11 using Luciferin-4A as substrate incubated for 60 mins in presence of NADPH regenerating system by luminescenc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2023
Entry Details
PubMed
TargetCytochrome P450 4A11(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50591501(CHEMBL5183418)
Affinity DataIC50: 390nMAssay Description:Inhibition of human recombinant CYP4A11 using Luciferin-4A as substrate incubated for 60 mins in presence of NADPH regenerating system by luminescenc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2023
Entry Details
PubMed
TargetCytochrome P450 4A11(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50591514(CHEMBL5184859)
Affinity DataIC50: 410nMAssay Description:Inhibition of human recombinant CYP4A11 using Luciferin-4A as substrate incubated for 60 mins in presence of NADPH regenerating system by luminescenc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2023
Entry Details
PubMed
TargetCytochrome P450 4F2(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50591495(CHEMBL5181522)
Affinity DataIC50: 510nMAssay Description:Inhibition of human recombinant CYP4F2 using Luciferin-4F2/3 as substrate incubated for 60 mins in presence of NADPH regenerating system by luminesce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2023
Entry Details
PubMed
TargetCytochrome P450 4A11(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50591516(CHEMBL5199197)
Affinity DataIC50: 530nMAssay Description:Inhibition of human recombinant CYP4A11 using Luciferin-4A as substrate incubated for 60 mins in presence of NADPH regenerating system by luminescenc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2023
Entry Details
PubMed
TargetCytochrome P450 4A11(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50591515(CHEMBL5203135)
Affinity DataIC50: 610nMAssay Description:Inhibition of human recombinant CYP4A11 using Luciferin-4A as substrate incubated for 60 mins in presence of NADPH regenerating system by luminescenc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2023
Entry Details
PubMed
TargetCytochrome P450 4F2(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50591507(CHEMBL5195609)
Affinity DataIC50: 640nMAssay Description:Inhibition of human recombinant CYP4F2 using Luciferin-4F2/3 as substrate incubated for 60 mins in presence of NADPH regenerating system by luminesce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2023
Entry Details
PubMed
TargetCytochrome P450 4F2(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50591508(CHEMBL5192567)
Affinity DataIC50: 640nMAssay Description:Inhibition of human recombinant CYP4F2 using Luciferin-4F2/3 as substrate incubated for 60 mins in presence of NADPH regenerating system by luminesce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2023
Entry Details
PubMed
TargetCytochrome P450 4A11(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50591519(CHEMBL5174407)
Affinity DataIC50: 640nMAssay Description:Inhibition of human recombinant CYP4A11 using Luciferin-4A as substrate incubated for 60 mins in presence of NADPH regenerating system by luminescenc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2023
Entry Details
PubMed
TargetCytochrome P450 4F2(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50591505(CHEMBL5199278)
Affinity DataIC50: 710nMAssay Description:Inhibition of human recombinant CYP4F2 using Luciferin-4F2/3 as substrate incubated for 60 mins in presence of NADPH regenerating system by luminesce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2023
Entry Details
PubMed
TargetCytochrome P450 4F2(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50591506(CHEMBL5189943)
Affinity DataIC50: 730nMAssay Description:Inhibition of human recombinant CYP4F2 using Luciferin-4F2/3 as substrate incubated for 60 mins in presence of NADPH regenerating system by luminesce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2023
Entry Details
PubMed
TargetCytochrome P450 4A11(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50591507(CHEMBL5195609)
Affinity DataIC50: 860nMAssay Description:Inhibition of human recombinant CYP4A11 using Luciferin-4A as substrate incubated for 60 mins in presence of NADPH regenerating system by luminescenc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2023
Entry Details
PubMed
TargetCytochrome P450 4A11(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50591518(CHEMBL5172100)
Affinity DataIC50: 1.30E+3nMAssay Description:Inhibition of human recombinant CYP4A11 using Luciferin-4A as substrate incubated for 60 mins in presence of NADPH regenerating system by luminescenc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2023
Entry Details
PubMed
TargetCytochrome P450 4A11(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50591500(CHEMBL5195099)
Affinity DataIC50: 1.60E+3nMAssay Description:Inhibition of human recombinant CYP4A11 using Luciferin-4A as substrate incubated for 60 mins in presence of NADPH regenerating system by luminescenc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2023
Entry Details
PubMed
TargetCytochrome P450 4A11(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50591503(CHEMBL5195431)
Affinity DataIC50: 6.00E+3nMAssay Description:Inhibition of human recombinant CYP4A11 using Luciferin-4A as substrate incubated for 60 mins in presence of NADPH regenerating system by luminescenc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2023
Entry Details
PubMed
TargetCytochrome P450 4A11(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50591495(CHEMBL5181522)
Affinity DataIC50: 7.40E+3nMAssay Description:Inhibition of human recombinant CYP4A11 using Luciferin-4A as substrate incubated for 60 mins in presence of NADPH regenerating system by luminescenc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2023
Entry Details
PubMed
TargetCytochrome P450 4A11(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50591511(CHEMBL5182293)
Affinity DataIC50: 9.30E+3nMAssay Description:Inhibition of human recombinant CYP4A11 using Luciferin-4A as substrate incubated for 60 mins in presence of NADPH regenerating system by luminescenc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2023
Entry Details
PubMed
TargetCytochrome P450 4F2(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50591511(CHEMBL5182293)
Affinity DataIC50: 1.10E+4nMAssay Description:Inhibition of human recombinant CYP4F2 using Luciferin-4F2/3 as substrate incubated for 60 mins in presence of NADPH regenerating system by luminesce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2023
Entry Details
PubMed
TargetCytochrome P450 4F2(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50591512(CHEMBL5170975)
Affinity DataIC50: 1.20E+4nMAssay Description:Inhibition of human recombinant CYP4F2 using Luciferin-4F2/3 as substrate incubated for 60 mins in presence of NADPH regenerating system by luminesce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2023
Entry Details
PubMed
TargetCytochrome P450 4A11(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50591513(CHEMBL5181516)
Affinity DataIC50: 1.90E+4nMAssay Description:Inhibition of human recombinant CYP4A11 using Luciferin-4A as substrate incubated for 60 mins in presence of NADPH regenerating system by luminescenc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2023
Entry Details
PubMed
Displayed 1 to 50 (of 52 total ) | Next | Last >>
Jump to: